Skip to content

The 'Surprise'-Question in Haematooncology (Pilotproject): Description and Exploration

The 'Surprise'-Question in Haematooncology (Pilotproject): Description and Exploration - PiPro (desciption) + SQual (exploration), here: Use of the ‘Surprise’- question in the care of outpatients of an academic hospital in Germany: Experiences and views of haemato-oncologists – a qualitative study (SQual)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014671
Enrollment
9
Registered
2018-05-16
Start date
2015-05-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological neoplasia and solid tumours

Interventions

Group 1: quantitative: 'Surprise'-Question in hemato-oncological outpatients
physicians in charge routinely assess their patients with the 'Surprise'-Question. qualitative: physicians who used the 'Surprise'-Question will be interviewed (semi-structured face-to-face interview

Sponsors

Universitätsmedizin III. Med. KlinikInterdisziplinäre Einrichtung für Palliativmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physician in a haemato-oncology outpatient facility of the III. Medical Clinic, University medical Center Mainz, Germany; experience with application of the 'Surprise'-Question

Exclusion criteria

Exclusion criteria: moved with unknown address

Design outcomes

Primary

MeasureTime frame
Quantitative part of the study: c-statistics 12 months after the last estimate; Qualitative part of the study: acceptance of the 'Surprise'-Question in haemato-oncologists applying the 'Surprise'-Question in haemato-oncology outpatients and meaning for integration of palliative care, and perceived difference between haematology and solid tumours

Secondary

MeasureTime frame
Quantitative part of the study: c-statistics of the first estimate, sensitivity, specifity, positive and negative predictive value, Kaplan-Meier-survial estimate 12 months after first and last estimate, the mentionned end points 3 months after first and last estimate, correlation of the 'Surprise'-Question accuracy with nearness to patients' death vs. learing effect in haemato-oncologists applying the 'Surprise'-Question

Countries

Germany

Contacts

Public ContactChristina Gerlach

Universitätsmedizin III. Med. KlinikInterdisziplinäre Einrichtung für Palliativmedizin

christna.gerlach@unimedizin-mainz.de00496131175931

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026